These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1942330)

  • 21. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands.
    Witjes WP; van der Meijden PM; Roos EP; Witjes JA; Steerenberg PA; Doesburg W; Debruyne FM
    Prog Clin Biol Res; 1992; 378():59-67. PubMed ID: 1301587
    [No Abstract]   [Full Text] [Related]  

  • 22. BCG in superficial bladder cancer: a review of phase III European trials.
    Pagano F; Bassi P; Milani C; Piazza N; Meneghini A; Garbeglio A
    Eur Urol; 1992; 21 Suppl 2():7-11. PubMed ID: 1396947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra.
    Bretton PR; Herr HW; Whitmore WF; Badalament RA; Kimmel M; Provet J; Oettgen HF; Melamed MR; Fair WR
    J Urol; 1989 Apr; 141(4):853-6. PubMed ID: 2926879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G
    Wien Klin Wochenschr; 1987 Feb; 99(4):114-8. PubMed ID: 3577186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravesical Calmette-Guérin bacillus therapy of bladder tumors].
    Uchida T; Muruyama M; Igarashi M; Kobayashi K; Mashimo S; Ishibashi A; Koshiba K; Shibuya M
    Nihon Hinyokika Gakkai Zasshi; 1987 Dec; 78(12):2087-97. PubMed ID: 3451983
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravesical bacille Calmette-Guérin in the treatment of carcinoma in situ or high-grade superficial bladder carcinoma after radiotherapy for bladder carcinoma.
    Palou J; Sánchez-Martín FM; Rosales A; Salvador J; Algaba F; Vicente J
    BJU Int; 1999 Mar; 83(4):429-31. PubMed ID: 10210566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer.
    Bassi P
    Surg Oncol; 2002 Jun; 11(1-2):77-83. PubMed ID: 12031870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a nordic study.
    Kaasinen E; Wijkström H; Malmström PU; Hellsten S; Duchek M; Mestad O; Rintala E;
    Eur Urol; 2003 Jun; 43(6):637-45. PubMed ID: 12767365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer.
    Bowyer L; Hall RR; Reading J; Marsh MM
    Br J Urol; 1995 Feb; 75(2):188-92. PubMed ID: 7850324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
    J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral or intravesical bacillus Calmette-Guerin immunoprophylaxis in bladder carcinoma.
    D'Ancona CA; Netto Júnior NR; Claro JA; Ikari O
    J Urol; 1991 Mar; 145(3):498-501. PubMed ID: 1997698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local bacillus Calmette-Guerin therapy for superficial bladder cancer: clinical, histological and ultrastructural patterns.
    Rigatti P; Colombo R; Montorsi F; Centemero A; Guazzoni G; Di Girolamo V; Galli L; Trabucchi E
    Scand J Urol Nephrol; 1990; 24(3):191-8. PubMed ID: 2237295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
    Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is second course intravesical Bacillus Calmette-Guerin therapy for recurrent carcinoma in situ of the bladder useful?].
    Yamada Y; Hara I; Kumano M; Furukawa J; Yamanaka K; Kamidono S
    Hinyokika Kiyo; 2005 Aug; 51(8):539-43. PubMed ID: 16164270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superficial urinary bladder cancer. Results from the Finnbladder studies and a review on instillation treatments.
    Jauhiainen K; Rintala E
    Ann Chir Gynaecol Suppl; 1993; 206():31-8. PubMed ID: 8291866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of carcinoma in situ of the urinary bladder].
    Harada Y; Seguchi T; Nonomura N; Kojima Y; Miki T; Okuyama A
    Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):693-7. PubMed ID: 9780653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
    Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H; Shirahase T; Kihara Y; Arai Y
    Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.